These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3258067)

  • 41. Primary alloreactive cytotoxic T-lymphocytes are not commonly restricted by self-HLA class I antigens.
    Young NT; Roelen DL; Wood KJ; Welsh KI; Morris PJ; Dallman MJ
    Hum Immunol; 1996 Sep; 50(1):38-46. PubMed ID: 8872173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells.
    Gallimore A; Hombach J; Dumrese T; Rammensee HG; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Oct; 28(10):3301-11. PubMed ID: 9808199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential reactivity of residual CD8+ T lymphocytes in TAP1 and beta 2-microglobulin mutant mice.
    Ljunggren HG; Van Kaer L; Ashton-Rickardt PG; Tonegawa S; Ploegh HL
    Eur J Immunol; 1995 Jan; 25(1):174-8. PubMed ID: 7843229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unrestricted T cell-mediated cytotoxicity to major histocompatibility antigen generated with tumor hybrid cells.
    Kambe M; Tachibana T
    Tohoku J Exp Med; 1994 Sep; 174(1):85-93. PubMed ID: 7863506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes.
    Achour A; Begue B; Gomard E; Paul P; Sayagh B; Van Pel A; Levy JP
    Eur J Immunol; 1986 Jun; 16(6):597-604. PubMed ID: 3522244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The peptide p2Ca is immunodominant in allorecognition of Ld by beta chain variable region V beta 8+ but not V beta 8- strains.
    Connolly JM
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11482-6. PubMed ID: 7972088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation of hen egg lysozyme-specific and major histocompatibility complex class I-restricted cytolytic T lymphocytes: recognition of cytosolic and secreted antigen expressed by transfected cells.
    Forquet F; Calin V; Trescol-Biemont MC; Kanellopoulos J; Mottez E; Kourilsky P; Rabourdin-Combe C; Gerlier D
    Eur J Immunol; 1990 Oct; 20(10):2325-32. PubMed ID: 2242761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of alpha 1 with alpha 2 region in class I MHC proteins contributes determinants recognized by antibodies and cytotoxic T cells.
    Stroynowski I; Clark S; Henderson LA; Hood L; McMillan M; Forman J
    J Immunol; 1985 Sep; 135(3):2160-6. PubMed ID: 2410513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
    Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
    Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. H-2Ld-alloreactive T cell hybridomas utilize diverse V alpha and V beta T cell receptor chains.
    Louie KA; Ochoa-Garay J; Chen PJ; McKinney D; Groshen S; McMillan M
    Mol Immunol; 1996 Jun; 33(9):747-58. PubMed ID: 8811070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T cell recognition of an engineered MHC class I molecule: implications for peptide-independent alloreactivity.
    Janković V; Remus K; Molano A; Nikolich-Zugich J
    J Immunol; 2002 Aug; 169(4):1887-92. PubMed ID: 12165513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Minor pocket B influences peptide binding, peptide presentation and alloantigenicity of H-2Kb.
    Yun TJ; Tallquist MD; Rohren EM; Sheil JM; Pease LR
    Int Immunol; 1994 Jul; 6(7):1037-47. PubMed ID: 7947455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of CTL in vivo by major histocompatibility complex class I-peptide complexes covalently associated on the cell surface.
    Anjuère F; Horvath C; Cerottini JC; Luescher IF
    Eur J Immunol; 1995 Jun; 25(6):1535-40. PubMed ID: 7614979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CTL escape viral variants. I. Generation and molecular characterization.
    Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
    Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell-mediated lympholytic responses against autologous cells modified with haptenic sulfhydryl reagents. V. H-2Ld self products are recognized by anti-AED-specific cytotoxic T cells.
    Levy RB; Shearer GM
    J Immunol; 1983 Apr; 130(4):1506-11. PubMed ID: 6187809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross-reactivity among evolutionarily distant major histocompatibility complex class I molecules (HLA-B27 and H-2Kk) revealed by xenoreactive T lymphocytes.
    Frangoulis B; Reboul M; Rocca A; Pla M
    Eur J Immunol; 1993 Feb; 23(2):338-42. PubMed ID: 8436169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peripheral tolerance in mice expressing a liver-specific class I molecule: inactivation/deletion of a T-cell subpopulation.
    Wieties K; Hammer RE; Jones-Youngblood S; Forman J
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6604-8. PubMed ID: 2395864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fine specificity of cytotoxic T lymphocytes directed against H-2Ld.
    Melief CJ; de Waal LP; van der Meulen MY; Iványi P; Melvold RW
    Immunogenetics; 1981; 12(1-2):75-88. PubMed ID: 6451577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strong alloantigenicity of the alpha-helices residues of the MHC class I molecule.
    Noun G; Reboul M; Abastado JP; Kourilsky P; Sigaux F; Pla M
    J Immunol; 1998 Jul; 161(1):148-53. PubMed ID: 9647218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
    Kuhröber A; Schirmbeck R; Reimann J
    Eur J Immunol; 1994 May; 24(5):1172-80. PubMed ID: 7514132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.